|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 3:410-419, 2004.
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc.
Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition*


From the Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
The 14-3-3 proteins constitute a family of abundant, highly conserved and broadly expressed acidic polypeptides that are involved in the regulation of various cellular processes such as cell-cycle progression, cell growth, differentiation, and apoptosis. One member of this family, the 14-3-3 isoform
, is expressed only in epithelial cells and is frequently down-regulated in a variety of human cancers. To determine the prevalence of 14-3-3
silencing in bladder cancer progression, we have studied the expression of this protein in normal urothelium and bladder transitional cell carcinomas (TCCs) of various grades and stages using two-dimensional gel electrophoresis in combination with Western blotting and immunohistochemistry. We show that the expression of 14-3-3
is down-regulated in invasive TCCs, particularly in lesions that are undergoing epithelial-to-mesenchymal conversion. Altered expression of 14-3-3
in invasive TCCs is not due to increased externalization of the protein nor to an aberrant proliferative potential of neoplastic cells. Furthermore, we found that impaired 14-3-3
expression is not associated with increased levels of the dominant-negative transcriptional regulator
Np63. Down-regulation of 14-3-3
was confirmed by indirect immunofluorescence using a peptide-based rabbit polyclonal antibody specific for this protein. We also show that the expression of 14-3-3
is highly up-regulated in pure squamous cell carcinomas. Taken together, these results provide evidence that deregulation of 14-3-3
may play a key role in bladder cancer progression, in particular in differentiation events leading to epithelial-to-mesenchymal transition and stratified squamous metaplasia.
To whom correspondence should be addressed: Department of Proteomics in Cancer, Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen Ø, Denmark. Tel.: 45-35257500; Fax: 45-35257721; E-mail: jom{at}cancer.dk and jec{at}cancer.dk
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. M. A. Moreira, T. Shen, G. Ohlsson, P. Gromov, I. Gromova, and J. E. Celis A Combined Proteome and Ultrastructural Localization Analysis of 14-3-3 Proteins in Transformed Human Amnion (AMA) Cells: Definition of A Framework to Study Isoform-Specific Differences Mol. Cell. Proteomics, July 1, 2008; 7(7): 1225 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suzuki, H. Watanabe, T. Mizutani, T. Sato, Y. Ohta, and T. Iguchi Global Gene Expression in Mouse Vaginae Exposed to Diethylstilbestrol at Different Ages. Experimental Biology and Medicine, May 1, 2006; 231(5): 632 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, T. Suzuki, J.-i. Akahira, M. Sakuma, S. Saitou, S. Okamoto, H. Niikura, K. Okamura, N. Yaegashi, H. Sasano, et al. 14-3-3{sigma} in Endometrial Cancer-A Possible Prognostic Marker in Early-Stage Cancer Clin. Cancer Res., October 15, 2005; 11(20): 7384 - 7391. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Faul, S. Huttelmaier, J. Oh, V. Hachet, R. H. Singer, and P. Mundel Promotion of importin {alpha}-mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14-3-3 J. Cell Biol., May 9, 2005; 169(3): 415 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. A. Moreira, G. Ohlsson, F. E. Rank, and J. E. Celis Down-regulation of the Tumor Suppressor Protein 14-3-3{sigma} Is a Sporadic Event in Cancer of the Breast Mol. Cell. Proteomics, April 1, 2005; 4(4): 555 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Celis, P. Gromov, T. Cabezon, J. M. A. Moreira, N. Ambartsumian, K. Sandelin, F. Rank, and I. Gromova Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment: A Novel Resource for Biomarker and Therapeutic Target Discovery Mol. Cell. Proteomics, April 1, 2004; 3(4): 327 - 344. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |